2Veiby G, Daltveit AK, Engelsen BA, et al. Pregnancy, delivery, and outcome for the child in maternal epilepsy[J]. Epilepsia, 2009, 50 (9): 2130-2139.
3Wide K, Winbladh B, Tomson T, et al. Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years[J]. Epilepsia, 2000, 41(7): 854-861.
4Borthen I, Eide MG, Daltveit AK, et al. Delivery outcome of women with epilepsy: a population-based cohort study[J]. BJOG, 2010, 117(12): 1537-1543.
5Lin HL, Chen YH, Lin HC. No increase in adverse pregnancy outcomes for women receiving antiepileptic drugs [J]. J Neurol, 2009, 256(10): 1742-1749.
6Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register [J]. J Neurol Neurosurg Psychiatry, 2006, 77(2): 193-198.
7Katz JM, Pacia SV, Devinsky O. Current management of epilepsy and pregnancy: fetal outcome, congenital malformations, and developmental delay [J]. Epilepsy Behav, 2001, 2(2): 119-123.
8Teramo K, Hiilesmaa V, Bardy A, et al. Fetal heart rate during a matemal grand mal epileptic seizure[J]. J Perinat Med, 1979, 7(1): 3-6.
9Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation[J]. Neurology, 2003, 61(6 Suppl 2): 35-42.
10Group ES. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry[J]. Neurology, 2006, 66(3): 354-360.
